A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
מצבים רפואיים
Nausea · Vomiting · Drug-Related Side Effects and Adverse Reactions · Neoplasms
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Marin Cancer Care, Greenbrae, California, United States
Contact: Principal Investigator (Cyrus Mazidi)City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California, United States
Contact: Principal Investigator (Sudarsan Kollimuttathuillam)Cancer and Blood Specialty Clinic, Los Alamitos, California, United States
Contact: Principal Investigator (Nihal Abdulla)BASS Cancer Center, Walnut Creek, California, United States
Contact: Principal Investigator (Jewel Johl)UCHealth Harmony, Fort Collins, Colorado, United States
Contact: Principal Investigator (Steven Schuster)Clavis Medical, Miami Lakes, Florida, United States
Contact: Principal Investigator (Eloy Roman)BRCR Global - Tamarac, Tamarac, Florida, United States
Contact: Principal Investigator (Chintan Gandhi)Summit Cancer Care, PC, Savannah, Georgia, United States
Contact: Principal Investigator (Michael Chahin)Hope and Healing Cancer Services, Hinsdale, Illinois, United States
Contact: Principal Investigator (Srilata Gundala)Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
Contact: Principal Investigator (Tarah Ballinger)North Mississippi Hematology and Oncology Associates, Tupelo, Mississippi, United States
Contact: Principal Investigator (Amit Jain)Laura and Isaac Perlmutter Cancer Center, New York, New York, United States
Contact: Principal Investigator (Olivia Seecof)New York Cancer and Blood Specialists, Shirley, New York, United States
Contact: Principal Investigator (Richard Zuniga)Oncology Specialists of Charlotte, Charlotte, North Carolina, United States
Contact: Principal Investigator (Justin Favaro)Southern Oncology Specialists, Huntersville, North Carolina, United States
Contact: Principal Investigator (William Mitchell)Asante Rogue Regional Medical Center, Medford, Oregon, United States
Contact: Principal Investigator (Alison Savage)World Research Link, Baytown, Texas, United States
Contact: Principal Investigator (Amir Rasheed)John Peter Smith Hospital, Fort Worth, Texas, United States
Contact: Principal Investigator (Kalyani Narra)Community Cancer Trials of Utah, Ogden, Utah, United States
Contact: Principal Investigator (Carl Gray)Cancer Care Northwest, Spokane, Washington, United States
Contact: Principal Investigator (Saritha Thumma)Ballarat Health Services, Ballarat Central, Australia
Contact: Principal Investigator (Sharad Sharma)Bendigo Health Care Group, Bendigo, Australia
Contact: Principal Investigator (Danielle Forbes)WA Country Health Service Trial Centre, Perth, Australia
Contact: Principal Investigator (Wei-Sen Lam)Goulburn Valley Health, Shepparton, Australia
Contact: Principal Investigator (Myron Klevansky)Latrobe Regional Health, Traralgon, Australia
Contact: Principal Investigator (Quan Tran)The First People's Hospital of Changde City, Changde, China
Contact: Principal Investigator (Tao Wu)Zhujiang Hospital, Guangzhou, China
Contact: Principal Investigator (Xigang Hu)Zhejiang Provincial People's Hospital, Hangzhou, China
Contact: Principal Investigator (Liu Yang)Jiangmen Center Hospital, Jiangmen, China
Contact: Principal Investigator (XIAOPING LI)The First Affiliated Hospital of Henan University of Science &Technology, Luoyang, China
Contact: Principal Investigator (Jun Yao)Sainte Catherine Institut du Cancer Avignon Provence, Avignon, France
Contact: Principal Investigator (Alma Stancu)Centre Hospitalier d'Annecy, Epagny Metz-Tessy, France
Contact: Principal Investigator (Melodie Carbonnaux)Clinique Victor Hugo Le Mans, Le Mans, France
Contact: Principal Investigator (Yoann Pointreau)Aou Ospedali Riuniti Umberto I, Ancona, Italy
Contact: Principal Investigator (Rossana Berardi)Azienda Ospedaliero Universitaria, Modena, Italy
Contact: Principal Investigator (Roberto Sabbatini)Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
Contact: Principal Investigator (Luca Galli)AULSS8 Berica-Ospedale S.Bortolo, Vicenza, Italy
Contact: Principal Investigator (Maria Vittoria Resi)Himeji Medical Center, Himeji, Japan
Contact: Principal Investigator (Tetsuji Kawamura)The Cancer Institute Hospital of JFCR, Kōtoku, Japan
Contact: Principal Investigator (Naoki Fukuda)Kyoto University Hospital, Kyoto, Japan
Contact: Principal Investigator (TAKAKO NAKAJIMA)Shizuoka Cancer Center, Nagaizumi-cho,Sunto-gun, Japan
Contact: Principal Investigator (Tateaki Naito)SC Memorial Healthcare International SRL, Bucharest, Romania
Contact: Principal Investigator (Ingrid Iordan)Spitalul Clinic Colentina, Bucharest, Romania
Contact: Principal Investigator (Andrei Popescu)Spitalul Clinic Colțea, Bucharest, Romania
Contact: Principal Investigator (Ileana-Raluca Patru)Centrul de Oncologie "Sfântul Nectarie", Craiova, Romania
Contact: Principal Investigator (Michael Schenker)Ovidius Clinical Hospital OCH, Ovidiu, Romania
Contact: Principal Investigator (Laura Mazilu)Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Contact: Principal Investigator (Margarita Majem Tarruella)FutureMeds - Madrid, Madrid, Spain
Contact: Principal Investigator (Esther Holgado)Hospital General Universitario Gregorio Marañon, Madrid, Spain
Contact: Principal Investigator (Silvia Garcia Adrian)Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Contact: Principal Investigator (Imanol Martinez Salas)Hospital de Mataró, Mataró, Spain
Contact: Principal Investigator (Laura Punti Brun)Hospital Universitario Virgen de la Victoria, Málaga, Spain
Contact: Principal Investigator (Jose Carlos Benitez Montañez)Hospital Universitari Sant Joan de Reus, Reus, Spain
Contact: Principal Investigator (Kepa Amillano Parraga)E-Da Cancer Hospital, Kaohsiung City, Taiwan
Contact: Principal Investigator (Kun-Ming Rau)National Cheng Kung University Hospital, Tainan, Taiwan
Contact: Principal Investigator (Chun-Hui Lee)Chi Mei Hospital - Liouying Branch, Tainan, Taiwan
Contact: Principal Investigator (Wen-Tsung Huang)Taipei Veterans General Hospital, Taipei, Taiwan
Contact: Principal Investigator (Muh-Hwa Yang)Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan
Contact: Principal Investigator (Chia-Hsun Hsieh)Adana Medical Park Seyhan Hastanesi, Adana, Turkey (Türkiye)
Contact: Principal Investigator (Ahmet Taner Sumbul)Ankara Bilkent Şehir Hastanesi, Ankara, Turkey (Türkiye)
Contact: Principal Investigator (Mehmet Ali Nahit Sendur)Antalya Egitim ve Arastırma Hastanesi, Antalya, Turkey (Türkiye)
Contact: Principal Investigator (Derya KIVRAK SALIM)Ege Universitesi Hastanesi, Bornova, Turkey (Türkiye)
Contact: Principal Investigator (Tuncay Goksel)Dicle Üniversitesi, Diyarbakır, Turkey (Türkiye)
Contact: Principal Investigator (Muhammet kaplan)Trakya University, Edirne, Turkey (Türkiye)
Contact: Principal Investigator (Muhammet Hacioglu)Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi, Gaziantep, Turkey (Türkiye)
Contact: Principal Investigator (tulay kus)T.C. Sağlik Bakanliği- Marmara Üniversitesi İstanbul Pendik Eğitim Ve Araştirma Hastanesi, Pendik, Turkey (Türkiye)
Contact: Principal Investigator (Ibrahim Bayoglu)Sakarya Training and Research Hospital, Sakarya, Turkey (Türkiye)
Contact: Principal Investigator (Ilhan Hacibekiroglu)
מובילי המחקר
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company